Adverse effect of other viral vaccines, initial encounter

This code signifies an undesirable or harmful reaction experienced by a patient following the administration of a viral vaccine not otherwise specified. These reactions are typically unintended and can range in severity, occurring as a direct consequence of the vaccine itself rather than an error in administration. This specific code is for the initial presentation of such an adverse effect.

Apply this code when documenting a patient's first encounter for symptoms or conditions directly attributable to an adverse reaction to a viral vaccine, where the specific type of viral vaccine is not detailed in the medical record. This includes reactions like fever, rash, localized swelling, or systemic symptoms that develop after vaccination. It is appropriate when the vaccine involved is not a COVID-19, measles, mumps, rubella, or influenza vaccine.

• Always sequence this code after the code for the specific manifestation of the adverse effect.
• Ensure documentation clearly links the adverse effect to a "viral vaccine" and specifies it as the "initial encounter."
• If the specific viral vaccine is known (e.g., yellow fever, polio), use a more specific code from the T50.B- series if available.